Current status of immunotherapy and gene therapy for high-grade gliomas (Q38072814)

28 August 2017

1 reference

title

Current status of immunotherapy and gene therapy for high-grade gliomas (English)

1 reference

28 August 2017

0 references

1 reference

James C Marsh

1

1 reference

28 August 2017

Justin Goldfarb

series ordinal

2

1 reference

28 August 2017

Timothy D Shafman

series ordinal

3

1 reference

28 August 2017

Aidnag Z Diaz

series ordinal

4

1 reference

28 August 2017

language of work or name

1 reference

1 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

20

1 reference

28 August 2017

1

1 reference

28 August 2017

43-48

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

28 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

American Society of Clinical Oncology 2011 CNS tumors update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Early-stage progress on glioma vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Vaccines for glioblastoma and high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Epidermal growth factor receptor vaccination for glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Immunotherapy for glioblastoma: the devil is in the details.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

How fine a slice: treatment of newly diagnosed glioblastoma with an epidermal growth factor receptor variant III peptide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Neural stem cells and the origin of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Cancer stem cells in nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Brain tumor stem cells: identification and concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Cancer stem cells and brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Progress on potential strategies to target brain tumor stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

An experimental study of dendritic cells transfected with cancer stem-like cells RNA against 9L brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Dendritic cell vaccines for cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma. Clinical article.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Autologous cancer vaccine: a novel formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Autologous formalin-fixed tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Pathological changes after autologous formalin-fixed tumor vaccine therapy combined with temozolomide for glioblastoma - three case reports - .

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Direct isolation of human central nervous system stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Learning enhances adult neurogenesis in the hippocampal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Neural stem cell-based gene therapy for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

Clinical opportunities in combining immunotherapy with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000107

10.1177/107327481302000107

21 January 2018

Identifiers

DOI

0 references

1 reference